Endothelial growth factors : a target for antiangiogenesisTOI, M.The Cancer journal (Print). 1995, Vol 8, Num 6, pp 315-319, issn 0765-7846Article

Circulating angiogenesis regulators in cancer patientsKUROI, K; TOI, M.The International journal of biological markers. 2001, Vol 16, Num 1, pp 5-26, issn 0393-6155Article

Serum lipid profiles in patients receiving endocrine treatment for breast cancer-the results from the Celecoxib Anti-Aromatase Neoadjuvant (CAAN) trialCHOW, L. W. C; CHENG, C. W. L; WONG, J. L. N et al.Biomedicine & pharmacotherapy. 2005, Vol 59, pp S302-S305, issn 0753-3322, SUP2Conference Paper

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinomaGASPARINI, G; TOI, M; GATTI, C et al.Journal of the National Cancer Institute. 1997, Vol 89, Num 2, pp 139-147, issn 0027-8874Article

Quantitative analysis of vascular endothelial growth factor in primary breast cancerTOI, M; KONDO, S; SUZUKI, H et al.Cancer. 1996, Vol 77, Num 6, pp 1101-1106, issn 0008-543XArticle

Protective effect of leuprolide acetate on 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in ratsINADA, K; TOMINAGA, T; TOI, M et al.European journal of surgical oncology. 1996, Vol 22, Num 6, pp 583-587, issn 0748-7983Article

Serum concentrations of hepatocyte growth factor in breast cancer patientsTANIGUCHI, T; TOI, M; INADA, K et al.Clinical cancer research. 1995, Vol 1, Num 9, pp 1031-1034, issn 1078-0432Article

Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancerTOI, M; INADA, K; HOSHINA, S et al.Clinical cancer research. 1995, Vol 1, Num 9, pp 961-964, issn 1078-0432Article

Adenocarcinoma of the submandibular gland with positive serum and tissue immunohistochemical staining for both CEA and CA 125 : report of a caseKASUGA, Y; NAKAI, A; MATSUNAGA, Y et al.Journal of laryngology and otology. 1994, Vol 108, Num 8, pp 719-721, issn 0022-2151Article

Tumor angiogenesis in an independent prognostic indicator in primary breast carcinomaTOI, M; KASHITANI, J; TOMINAGA, T et al.International journal of cancer. 1993, Vol 55, Num 3, pp 371-374, issn 0020-7136Article

Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancerTOI, M; NAKAMURA, T; MUKAIDA, H et al.Cancer. 1990, Vol 65, Num 9, pp 1980-1984, issn 0008-543X, 5 p.Article

Expression of human epidermal growth factor and its receptor in esophageal cancerMUKAIDA, H; YAMAMOTO, T; HIRAI, T et al.Japanese journal of surgery. 1990, Vol 20, Num 3, pp 275-282, issn 0047-1909Article

Correlation between docetaxel-induced skin toxicity and the use of steroids and H₂ blockers: a multi-institution surveyKAWAGUCHI, K; ISHIGURO, H; MORITA, S et al.Breast cancer research and treatment. 2011, Vol 130, Num 2, pp 627-634, issn 0167-6806, 8 p.Article

Study of COX-2, Ki67, and p53 expression to predict effectiveness of 5-flurouracil, epirubicin and cyclophosphamide with celecoxib treatment in breast cancer patientsCHOW, L. W. C; LOO, W. T. Y; WAI, C. C. Y et al.Biomedicine & pharmacotherapy. 2005, Vol 59, pp S298-S301, issn 0753-3322, SUP2Conference Paper

A novel assay for discovery and characterization of pro-apoptotic drugs and for monitoring apoptosis in patient seraBIVEN, K; ERDAL, H; SHOSHAN, M. C et al.Apoptosis (London). 2003, Vol 8, Num 3, pp 263-268, issn 1360-8185, 6 p.Article

Measurement of an apoptotic product in the sera of breast cancer patientsUENO, T; TOI, M; BIVEN, K et al.European journal of cancer (1990). 2003, Vol 39, Num 6, pp 769-774, issn 0959-8049, 6 p.Article

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancerUENO, T; TOI, M; SAJI, H et al.Clinical cancer research. 2000, Vol 6, Num 8, pp 3282-3289, issn 1078-0432Article

Metalloproteinases and tissue inhibitors of metalloproteinasesTOI, M; ISHIGAKI, S; TOMINAGA, T et al.Breast cancer research and treatment. 1998, Vol 52, Num 1-3, pp 113-124, issn 0167-6806Article

Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesisOIKAWA, T; ITO, H; ASHINO, H et al.European journal of pharmacology. 1993, Vol 241, Num 2-3, pp 221-227, issn 0014-2999Article

Epidermal growth factor receptor expression as a prognostic indicator in breast cancereTOI, M; OSAKI, A; YAMADA, H et al.European journal of cancer : (1990). 1991, Vol 27, Num 8, pp 977-980Article

Growth fractions of breast cancer in relation to epidermal gropwth factor receptor and estrogen receptorTOI, M; WADA, T; YAMADA, H et al.Japanese journal of surgery. 1990, Vol 20, Num 3, pp 327-330, issn 0047-1909Article

Immunocytochemicha and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasionTOI, M; HAMADA, Y; NAKAMURA, T et al.International journal of cancer. 1989, Vol 43, Num 2, pp 220-225, issn 0020-7136Article

Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among igh-risk women in JapanKONDO, M; HOSHI, S.-L; TOI, M et al.British journal of cancer. 2009, Vol 100, Num 2, pp 281-290, issn 0007-0920, 10 p.Article

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studiesTOI, M; IWATA, H; WATANABE, J et al.British journal of cancer. 2009, Vol 101, Num 10, pp 1676-1682, issn 0007-0920, 7 p.Article

Bilateral ischemic necrosis of the tongue due to disseminated intravascular coagulationKAMATANI, T; YAMASHITA, K; OKABAYASHI, T et al.International journal of oral and maxillofacial surgery. 2008, Vol 37, Num 8, pp 777-779, issn 0901-5027, 3 p.Article